Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.Nemo Money has over 1 million (1M+) downloads with a high rating of 4.6 stars from thousands of reviews. Join Nemo and trade with 0% commission.
RegisGrove Collaborative

Regis vs Grove Collaborative

Regis and Grove Collaborative Holdings are compared on this page to illustrate business models, financial performance, and market context in clear, neutral terms for readers. The layout presents how e...

Investment Analysis

Pros

  • Regis has demonstrated consistent revenue growth, with a 3.5% increase in 2025 compared to the previous year.
  • The company reported strong earnings growth, reaching $123.54 million in 2025, reflecting improved operational efficiency.
  • Regis trades at a low trailing price-to-earnings ratio of 0.61, suggesting it may be undervalued relative to earnings.

Considerations

  • Regis has a high beta of 1.77, indicating greater price volatility than the broader market.
  • Shares outstanding have increased by over 12% year-on-year, which could dilute shareholder value.
  • Technical indicators currently suggest negative momentum, with sell signals from both short and long-term moving averages.

Pros

  • Grove Collaborative operates a direct-to-consumer platform, providing flexibility and access to a growing e-commerce market.
  • The company has a diversified product range across household, personal care, and beauty categories, reducing reliance on any single segment.
  • Grove Collaborative recently underwent a reverse stock split, which may help stabilise its share price and improve market perception.

Considerations

  • Grove Collaborative reported a net loss of $22.44 million over the last twelve months, reflecting ongoing profitability challenges.
  • The company's market capitalisation is relatively small at $62 million, making it vulnerable to market volatility and liquidity risks.
  • Analyst consensus is mixed, with a 'Hold' rating and a price target below the current share price, suggesting limited upside.

Which Baskets Do They Appear In?

No baskets available in this category

Buy RGS or GROV in Nemo

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Comparisons

RegisPetMed Express

Regis vs PetMed Express

Regis vs PetMed Express: a neutral comparison

RegisVeru

Regis vs Veru

Regis vs Veru: comparing business models and outlook

RegisTDH

Regis vs TDH

Regis vs TDH: A comparison of business models

Frequently asked questions